OWP Pharmaceuticals Partners with EVERSANA for Launch of SUBVENITE® in the US Market OWP Pharmaceuticals has teamed up with EVERSANA to facilitate the U.S. launch of SUBVENITE® oral suspension, a breakthrough treatment for epilepsy and bipolar disorders.

OWP Pharmaceuticals Partners with EVERSANA for Launch of SUBVENITE® in the US Market #United_States #Lisle #EVERSANA #SUBVENITE® #OWP_Pharmaceuticals

Citius Oncology Partners with EVERSANA to Launch LYMPHIR™ in 2025 Citius Oncology announces an exclusive partnership with EVERSANA for the U.S. launch of LYMPHIR™, a breakthrough treatment for CTCL, set for late 2025.

Citius Oncology Partners with EVERSANA to Launch LYMPHIR™ in 2025 #United_States #Cranford #EVERSANA #LYMPHIR #Citius_Oncology

EVERSANA Merges with Waltz Health to Create a New Force in Pharma Commercialization and Prescription Drug Access #healthIT #EVERSANA #WaltzHealth
www.healthcareittoday.com/?p=2526707

EVERSANA Selected by Precigen for U.S. Launch of PAPZIMEOS Precigen has chosen EVERSANA for the U.S. commercialization of PAPZIMEOS, enhancing rare disease therapy access. Explore their partnership.

EVERSANA Selected by Precigen for U.S. Launch of PAPZIMEOS #USA #Chicago #EVERSANA #Precigen #PAPZIMEOS

Acquisitions: #Accenture > #NeuraFlash + #SI&C; #CrowdStrike > #Omun; #Databricks > #Tecton; #EVS > #Telemetrics; #Fullcast > #Atrium; #IDF > #FPV; #MPulse > #Clarity; #Okta > #Axiom; #OPTEL > #VanguardRobotics; #Pepper > #Kimelo; #Vertiv > #WayLay; #WaltzHealth > #Eversana

EVERSANA and Waltz Health Merge to Revolutionize Pharma Commercialization and Enhance Prescription Drug Access The merger between EVERSANA and Waltz Health creates a groundbreaking healthcare platform, enhancing drug access and affordability in pharmaceutical commercialization.

EVERSANA and Waltz Health Merge to Revolutionize Pharma Commercialization and Enhance Prescription Drug Access #United_States #Chicago #EVERSANA #Waltz_Health #Pharma_Commercialization

EVERSANA Launches Innovative AI-Powered Life Sciences Marketing Agency on Google Cloud EVERSANA unveils a pioneering AI-driven life sciences marketing agency utilizing Google Cloud technology to enhance efficiency and reduce costs.

EVERSANA Launches Innovative AI-Powered Life Sciences Marketing Agency on Google Cloud #United_States #Chicago #Google_Cloud #EVERSANA #AI_Agency

EVERSANA unveils new AI-powered pharmacovigilance suite EVERSANA has launched a new pharmacovigilance platform to answer the need for advanced analytics and AI in drug safety monitoring and risk management.

#EVERSANA has launched a new #pharmacovigilance (PV) platform that answers the need to apply advanced #dataanalytics and #artificialintelligence to #drugsafety monitoring and #riskmanagement.

EVERSANA Launches ORCHESTRATE PV: A Revolutionary AI Solution in Pharmacovigilance EVERSANA has introduced ORCHESTRATE PV, an innovative AI-driven platform aiming to enhance drug safety processes. This solution promises improved efficiency and reduced manual workloads.

EVERSANA Launches ORCHESTRATE PV: A Revolutionary AI Solution in Pharmacovigilance #USA #Chicago #AI_Solutions #EVERSANA #ORCHESTRATE_PV

EVERSANA Launches AI Accelerator to Transform Life Sciences Commercialization EVERSANA introduces an AI Accelerator aimed at revolutionizing commercialization within the life sciences sector. Harnessing AI's potential, it promises groundbreaking solutions.

EVERSANA Launches AI Accelerator to Transform Life Sciences Commercialization #USA #Chicago #Life_Sciences #EVERSANA #AI_Accelerator

EVERSANA expands commercialisation portfolio with OS Therapies and Iterum Therapeutics partnerships

#EVERSANA #OSTherapies #IterumTherapeutics #OSTHER2 #paediatricosteosarcoma #immunotherapy #OrphanDesignation #FastTrackDesignation #RarePediatricDiseaseDesignation #BLAsubmission #EVERSANAONCOLOGY #ORLYNVAH #ProductCommercializationAgreement #oralpenemantibiotic
pharmaphorum.com/market-acces...

EVERSANA Expands Operations with New Distribution Center for Improved Logistics Capabilities EVERSANA is enhancing its logistics operations with a new 358,000 sq ft center, boosted cold chain capacity, and AI-powered solutions.

EVERSANA Expands Operations with New Distribution Center for Improved Logistics Capabilities #USA #Memphis #logistics #AI_Technology #EVERSANA

EVERSANA Launches EVERSANA ORCHESTRATE™ MLR: A Game-Changer in Medical, Legal, and Regulatory Review EVERSANA has introduced the ORCHESTRATE™ MLR platform, leveraging AI to streamline medical, legal, and regulatory processes in the life sciences sector.

EVERSANA Launches EVERSANA ORCHESTRATE™ MLR: A Game-Changer in Medical, Legal, and Regulatory Review #EVERSANA #ORCHESTRATE #AI-Powered_Solution

EVERSANA joins with Veeva in push to 'pharmatise AI' EVERSANA has joined the growing roster of companies partnering with Veeva on the development of GenAI applications for the life sciences industry.

NEWS: Commercial services player #EVERSANA has joined the growing number of companies partnering with #VeevaSystems – a specialist in #cloudsoftware for the #lifesciences industry – on the development of #artificialintelligence solutions for the sector.

5 ways to address pricing and access challenges across the European landscape EVERSANA discuss 5 effective strategies for overcoming pricing and access challenges in the European healthcare landscape. Learn about HTA, risk-sharing, data utilisation, orphan drugs, and more.

From prolonged timelines for #HealthTechnologyAssessments to disparities in #access between wealthier and less affluent nations in #Europe - Paolo Correale provides an overview of the current landscape and impact on #patientaccess.
#pricing #reimbursement #EVERSANA

pharmaphorum.com/market-acces...

Transformative Collaboration Between Lyfegen and EVERSANA to Enhance Drug Pricing Accessibility Through AI Insights Lyfegen has partnered with EVERSANA to leverage AI-driven insights, aiming to transform drug pricing and improve global access significantly.

Transformative Collaboration Between Lyfegen and EVERSANA to Enhance Drug Pricing Accessibility Through AI Insights #Switzerland #Drug_Pricing #EVERSANA #Basel #Lyfegen

Revolutionizing Drug Pricing and Access Through AI: Lyfegen and EVERSANA's Game-Changing Collaboration Lyfegen and EVERSANA have teamed up to harness AI for better drug pricing and access. This partnership aims to enhance decision-making in healthcare efficiently.

Revolutionizing Drug Pricing and Access Through AI: Lyfegen and EVERSANA's Game-Changing Collaboration #Switzerland #Drug_Pricing #EVERSANA #Basel #Lyfegen

First post here!

At Frontiers Health Italy 2024, we explored how ai can simulate doctors conversations. How AI agents, specifically trained, can simulate doctors with different specializations and handle complex, scenario-specific situations.

#AI #virtualcare #AIAgents #eversana

EVERSANA Achieves Key Accreditations for Specialty Pharmacy and Rare Disease Care Excellence EVERSANA has received prestigious accreditations for its specialty pharmacy services, ensuring exceptional care for rare disease patients. Discover more about their commitment to quality.

EVERSANA Achieves Key Accreditations for Specialty Pharmacy and Rare Disease Care Excellence #United_States #St._Louis #Specialty_Pharmacy #EVERSANA #Rare_Disease_Care

Partner wall di Frontiers Health Italia 2024. C'è anche il logo di MioPharma Blog (indizio: fra i media partner)

Con Marcello Cattani, Presidente di Farmindustria e Presidente e Amministratore Delegato di Sanofi Italia, dopo l'intervista

Welcome Health Innovators

Con Massimo Piana, Direttore Operations e Innovation UniSalute ed Amministratore Delegato UniSalute Servizi (Unipol Gruppo), dopo l'intervista

A una settima di distanza, immagini da #FrontiersHealth Italia 2024! Un'appuntamento che ha visto l'ecosistema della #digitalhealth ritrovarsi per fare il punto su #innovazione, #terapiedigitali e #intelligenzaartificiale in ambito #sanità e #salute
#FHITA24 #Eversana @miopharmablog.bsky.social

ConTIPI Medical and EVERSANA Launch Non-Surgical ProVate Device for Pelvic Organ Prolapse in the U.S. ConTIPI Medical and EVERSANA have announced the U.S. launch of ProVate, a non-surgical device designed for women with pelvic organ prolapse, enhancing healthcare options.

ConTIPI Medical and EVERSANA Launch Non-Surgical ProVate Device for Pelvic Organ Prolapse in the U.S. #United_States #Chicago #ProVate #ConTIPI_Medical #EVERSANA

Tutto pronto per #FrontiersHealth Italia 2024, il meeting dell'ecosistema italiano della #digitalhealth. Evento organizzato da #EVERSANA, con #Assolombarda, Cluster lombardo scienze della vita, #Farmindustria, #FISM e #FondazioneEnpam.

Consulta il programma: 2024ita.frontiers.health/agenda